German University Hospital orders Nexstim NBS system with NexSpeech

News
- 28/01/2021

Helsinki, Finland: 28 January 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a University Hospital in Germany has ordered a Nexstim NBS System with NexSpeech.

The hospital is a new customer for Nexstim. The NBS System with NexSpeech will be used for neuroscientific research and diagnostics.

Nexstim NBS System uses the unique SmartFocus® navigated transcranial magnetic stimulation (nTMS) technology which enables accurate and precise stimulation of the brain. SmartFocus® nTMS mapping conducted with NBS system is a non-invasive and accessible way of diagnosing the tumour’s or other lesion’s location. In addition to motor mapping, NBS System can be used also for locating language eloquent areas when used together with NexSpeech module.

Further information on Nexstim’s website.